✦ LIBER ✦

Innovations in Stem Cell Transplantation || Tumorablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of High-Risk and Refractory Leukemia — New Concepts and Clinical Practice

✍ Scribed by Demirer, Taner

Book ID: 120524133
Publisher: InTech
Year: 2013
Weight: 338 KB
Category: Article
ISBN: 9535109804
DOI: 10.5772/53031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[Cancer Treatment and Research] Hematopo

[Cancer Treatment and Research] Hematopoietic Stem Cell Transplantation Volume 144 || Advancement and Clinical Implications of HLA Typing in Allogeneic Hematopoietic Stem Cell Transplantation

✍ Bishop, Michael R. 📂 Article 📅 2008 🏛 Springer US ⚖ 489 KB

Allogeneic Hematopoietic Stem Cell Trans

Allogeneic Hematopoietic Stem Cell Transplantation in Adolescent and Adult Patients with High-Risk T Cell Acute Lymphoblastic Leukemia

✍ Bakr, Mohammad; Rasheed, Walid; Mohamed, Said Y.; Al-Mohareb, Fahad; Chaudhri, N 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Outcomes of unrelated cord blood transpl

Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia

✍ Jacobsohn, D A; Hewlett, B; Ranalli, M; Seshadri, R; Duerst, R; Kletzel, M 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 137 KB

23. Outcomes of unrelated cord blood tra

23. Outcomes of unrelated cord blood transplants and allogeneic related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia

✍ D.A. Jacobsohn; B. Hewlett; R. Seshadri; M. Ranalli; R. Duerst; M. Kletzel 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Voriconazole Exposure and the Risk of Cu

Voriconazole Exposure and the Risk of Cutaneous Squamous Cell Carcinoma in Allogeneic Hematopoietic Stem Cell Transplant Patients

✍ Hashmi, Shahrukh; Wojenski, Daniel; Merten, Julianna; Wolf, Robert; Bartoo, Gabr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Comparison of allogeneic stem cell trans

Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

✍ Apostolia-Maria Tsimberidou; Niki Stavroyianni; Nora Viniou; Maria Papaioannou; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

## Abstract ## BACKGROUND Postremission therapy is critical in maintaining complete remission (CR) in patients with de novo acute myelogenous leukemia (AML). The aim of this trial was to compare allogeneic stem cell transplantation (SCT), high‐dose cytarabine (ara‐C; HiDAC), and autologous SCT as